Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.

× No keyword cloud information.

23 in total

1. Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins.

Authors: E Nègre; M L Chance; S Y Hanboula; M Monsigny; A C Roche; R M Mayer; M Hommel
Journal: Antimicrob Agents Chemother Date: 1992-10 Impact factor: 5.191

2. Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Authors: C R Alving; E A Steck; W L Chapman; V B Waits; L D Hendricks; G M Swartz; W L Hanson
Journal: Proc Natl Acad Sci U S A Date: 1978-06 Impact factor: 11.205

Review 3. Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience.

Authors: A Coune
Journal: Infection Date: 1988 May-Jun Impact factor: 3.553

4. Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.

Authors: J S Weldon; J F Munnell; W L Hanson; C R Alving
Journal: Z Parasitenkd Date: 1983

Review 5. Similarities of lipid metabolism in mammalian and protozoan cells: an evolutionary hypothesis for the prevalence of atheroma.

Authors: W E Ormerod; S Venkatesan
Journal: Microbiol Rev Date: 1982-09

6. Incorporation of [1-14C]octadecanol into the lipids of Leishmania donovani.

Authors: H Herrmann; G Gercken
Journal: Lipids Date: 1980-03 Impact factor: 1.880

7. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.

Authors: Swati Pal; Rajesh Ravindran; Nahid Ali
Journal: Antimicrob Agents Chemother Date: 2004-09 Impact factor: 5.191

8. Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.

Authors: Flávia M Ferreira; Renata A O Castro; Mauricio A Batista; Fernanda M O Rossi; Denise Silveira-Lemos; Frédéric Frézard; Sandra A L Moura; Simone A Rezende
Journal: Parasitol Res Date: 2013-11-30 Impact factor: 2.289

9. Development of new derivatives of primaquine by association with lysosomotropic carriers.

Authors: A U Trouet; P Pirson; R Steiger; M Masquelier; R Baurain; J Gillet
Journal: Bull World Health Organ Date: 1981 Impact factor: 9.408

10. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys.

Authors: J D Berman; W L Hanson; W L Chapman; C R Alving; G Lopez-Berestein
Journal: Antimicrob Agents Chemother Date: 1986-12 Impact factor: 5.191